Skip to main content

Table 1 Patient baseline characteristics

From: Is prophylactic lateral lymph node dissection needed for lower rectal cancer? A single-center retrospective study

Characteristic

Dissection group

(n = 37)

Non-dissection group

(n = 264)

p value

Sex

   

 Male

21 (56.8)

197 (74.6)

 

 Female

16 (43.2)

67 (25.4)

0.02

Age (years)

60.38 ± 9.82

64.87 ± 11.52

0.01

 

6.71 ± 5.45

21.18 ± 132.85

0.60

CEA (ng/mL)

   

 > 5.0

15 (40.5)

112 (42.4)

 

 ≤ 5.0

22 (59.5)

152 (57.6)

0.83

 

22.19 ± 3.44

23.42 ± 11.90

0.37

BMI (kg/m2)

   

 ≥ 25

7 (18.9)

64 (24.2)

 

 < 25

30 (81.1)

200 (75.8)

0.48

History of laparotomy

   

 Yes

11 (29.7)

79 (29.9)

 

 No

26 (70.3)

185 (70.1)

0.98

ASA-PS

   

 1

27 (73.0)

101 (38.3)

 

 2

9 (24.3)

128 (48.5)

 

 3

1 (2.7)

35 (13.3)

 < 0.001

Preoperative diagnosis

   

 Depth

   

  T3

32 (86.5)

219 (83.0)

 

  T4

5 (13.5)

45 (17.0)

0.59

 Lymph node metastasis (central direction)

   

  Yes

26 (70.3)

135 (51.1)

 

  No

11 (29.7)

129 (48.9)

0.03

Surgery

   

 Approach

   

  Laparotomy

37 (100.0)

37 (14.0)

 

  Laparoscopy

0 (0.0)

227 (86.0)

 < 0.001

 Including anastomosis

   

  Yes

28 (75.7)

221 (83.7)

 

  No

9 (24.3)

43 (16.3)

0.23

Pathology

   

 Histopathology

   

  Well/moderate

36 (97.3)

236 (89.4)

 

  Other

1 (2.7)

28 (10.6)

0.10

 Depth

   

  T1–2

6 (16.2)

79 (29.9)

 

  T3–4

31 (83.8)

185 (70.1)

0.08

 Lymph node metastasis

   

  Central direction

20 (54.1)

122 (46.2)

0.37

  Lateral

2

 

 Stage

   

  I/II

17 (45.9)

142 (53.8)

 

  III

20 (54.1)

122 (46.2)

0.37

 Lymphatic invasion

   

  Yes

11 (29.7)

78 (29.8)

 

  No

26 (70.3)

184 (70.2)

0.996

 Venous invasion

   

  Yes

27 (73.0)

193 (73.7)

 

  No

10 (27.0)

69 (26.3)

0.93

 Nerve invasion

   

  Yes

19 (54.3)

105 (41.8)

 

  No

16 (45.7)

146 (58.2)

0.16

 Postoperative adjuvant therapy

   

  Yes

15 (40.5)

92 (34.8)

 

  No

22 (59.5)

172 (65.2)

0.50

  1. Data are presented as n (%) or mean ± standard deviation
  2. ASA-PS American Society of Anesthesiologists physical status, BMI body mass index, CEA carcinoembryonic antigen